InvestLog
IMRX logo

IMRX

Immuneering CorporationNASDAQHealthcare
$5.45+2.25%ClosedMarket Cap: $197.8M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-09Needham—Buy—
2025-11-13Chardan Capital—Buy—
2025-09-30HC Wainwright & Co.—Buy—
2025-09-26Chardan Capital—Buy—
2025-09-25Oppenheimer—Outperform—
2025-09-15Needham—Buy—
2025-08-14Chardan Capital—Buy—
2025-06-18Mizuho—Outperform—
2025-06-18Chardan Capital—Buy—
2025-06-18Needham—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-1.35$16.0M4
Sun Dec 31$-1.29$51.8M4
Mon Dec 31$-0.64$109.1M2
Tue Dec 31$0.07$191.8M2